Why Attend?
- Learn about the recent trends and advancements in Real-World Evidence Generation
- Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
- Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers.
Key Highlights
- Regulatory view around data quality & data standards.
- Leveraging RWE for improving market access.
- The adoption & role of AI & ML in clinical trials.
- Real-world evidence & Digital Health – The expanded role of RWE for digital health.
- Panel Discussion on lessons learned from the recent results of the FDA’s pilot program RCT DUPLICATE.
- Real-World Data & Advanced Analytics.
- RWE to inform decision making process in rare diseases where there is lack of evidence.
